Orphan Drugs: In Development

polycythemia vera-Disorder of the bone marrow that causes an increased production of red blood cells. porphyria-Any of a group of uncommon inherited disorders caused by accumulation in the body of substances called porphyrins, which build up because of deficiencies of various enzymes in the body. Victims of porphyria often have a rash or skin blistering brought on by sunlight and may have abdominal pain and nervous system disturbances from certain drugs. Three of the six types of porphyria are acute intermittent porphyria, variegata porphyria, and heredita coproporphyria. precocious puberty-Onset of early puberty. It can be a normal variant or familial trait, or be caused by serious diseases, such as hypothalamic lesions, encephalitis and some tumors. If not detected early, children may be dwarfed. prophylaxis-Treatment intended to preserve health and prevent the spread of disease. pulmonary-Pertaining to the lungs. Raynaud's disease-A disorder of the blood vessels in which exposure to cold causes the small arteries supplying the fingers and toes to contract suddenly, cutting off blood flow to the digits, which become pale. When the symptoms develop with no known cause, it is called Raynaud's disease. When symptoms are secondary to some other condition, the disorder is termed Raynaud's phenomenon and may have more serious long-term consequences. The phenomenon is present in 90% of patients with systemic sclerosis, a chronic disorder characterized by diffuse fibrosis (overgrowth of scar or connective tissue) of the skin and internal organs. renal-Relates to kidneys. respiratory distress syndrome (RDS) (hyaline membrane disease-HMD)Lung disorder of premature infants characterized by respiratory distress and cyanosis (lack of oxygen in blood). RDS is caused by a deficiency of surfactant, a substance that coats the inner lining of the lungs and prevents them from collapsing during exhalation. respiratory syncytial virus disease (RSV)-One of the most important causes of lower respiratory tract disease in children accounting for over 90% of cases of bronchiolitis. Symptoms include wheezing, fever, cough and difficulty feeding. In severe cases, cyanosis (bluish discoloration of skin or mucous membranes due to deficient oxygenation of the blood) can result. retinitis pigmentosa-Degeneration in both eyes of the rods and cones of the retina-the light-sensitive membrane that lines the inside of the back of the eye on which images are cast by the cornea and lens. Usually has a genetic basis. The first symptom is usually night blindness, progressing to a ring-shaped area of blindness that gradually extends to lessen the field of vision. severe combined immunodeficiency disease (SCID)-Combined deficiency of white blood cells (lymphocytes and Blymphocytes), leaving a patient virtually defenseless against all types of infection. Infants with SCID usually die within two years. sickle cell anemia-Inherited blood disorder in which red cells are abnormal in shape and contain an abnormal oxygencarrying pigment called hemoglobin S, resulting in chronic, severe anemia and the characteristic sickle shape of the red cell. Caused by mutation of the gene that codes for hemoglobin. Sjogren's syndrome-A condition in which the eyes, mouth and vagina become excessively dry. It tends to occur with certain autoimmune disorders, such as rheumatoid arthritis, but the exact cause is unknown. Sufferers are mostly middle-aged, postmenopausal women. sleeping sickness-Serious infectious disease spread by tsetse fly bites, which transmit the protozoan parasite Trypanosoma brucei. In humans, the parasites multiply and spread to the blood, lymph nodes, heart and brain, and can be fatal. Trypanosoma brucei gambiense sleeping sickness is a human disease with human-to-fly-to-human transmission in which humans serve as reservoir hosts. spasticity, intractable-Rigidity of muscles, causing stiffness and restriction of movement, which can become resistant to treatment (intractable). strabismus-Abnormal deviation of one eye in relation to the other. systemic-Affecting the whole body. thrombocythemia, essential-Characterized by spontaneous bleeding, irregularly shaped platelets and aggregates of them. Can lead to or accompany other conditions, including leukemia and polycythemia vera. thrombocytopenia-A reduction in the number of platelet cells in the blood, which causes a tendency to bleed, especially from the smaller blood vessels. thrombosis-The formation of a blood clot within the heart or a blood vessel. trigeminal neuralgia-A severe paroxysm of pain affecting one side of the face, caused by irritation of or damage to the trigeminal nerve (the fifth cranial nerve that divides into three main branches, which are the ophthalmic, maxillary and mandibular nerves). Turner's syndrome-Girls born with a missing X chromosome are characterized by shortness of stature, absence or very retarded development of secondary sexual characteristics, absence of menstruation, narrowing of the aorta, eye and bone abnormalities, some mental retatrdation and infertility. uremic osteodystrophy-Defect of bone formation caused by excess urea (waste product of protein breakdown and the main nitrogen-containing constituent of urine). ventricular fibrillation-Rapid, ineffective, uncoordinated contractions cause the heart to stop pumping blood effectively and can be fatal unless normal heart beat is restored quickly. ventricular tachyarrhythmiasAbnormally fast heart beats initiated from irritable areas of the heart. Von Willebrand's disease-Inherited, lifelong bleeding disorder caused by a defective gene, which leads to deficiency of von Willebrand factor, without which the blood cannot coagulate properly. vulvar dystrophies-Disorders of the external, visible female genitalia. Wilson's disease-Inherited disorder in which copper accumulates in the liver, is slowly released into other parts of the body, and can eventually severely damage the liver and brain. xerostomia-Abnormal dryness of mouth. 22

/ 24

Actions

file_download Download Options Download this page PDF - Pages #1-24 Image - Page 22 Plain Text - Page 22

About this Item

Title
Orphan Drugs: In Development
Author
Pharmaceutical Research and Manufacturers of America
Canvas
Page 22
Publication
Pharmaceutical Manufacturers Association.
1992
Subject terms
reports
Item type:
reports

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0504.010
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0504.010/22

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0504.010

Cite this Item

Full citation
"Orphan Drugs: In Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0504.010. University of Michigan Library Digital Collections. Accessed June 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.